Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction

Urology

Volumn 52, Issue 5, 1998, Pages 739-743

  Kaplan, Steven A ^a   Reis, Rodolfo B ^b   Kohn, Ira J ^a   Shabsigh, Ridwan ^a   Te, Alexis E ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PROSTAGLANDIN E1;

ADULT; AGED; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; ASTHENIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VERTIGO;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ALPROSTADIL; DOXAZOSIN; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PENIS; PHENTOLAMINE; PILOT PROJECTS; VASODILATOR AGENTS;

EID: 0031795784     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00388-4     Document Type: Article

References (24)

1. NIH Consensus Conference. JAMA. 270:1993;83-90.
2. Krane R.J., Goldstein I., Saenz de Tejada I. Impotence. N Engl J Med. 321:1989;1648-1659.
3. Morales A. Nonsurgical management options in impotence. Hosp Pract. 28:1993;15-24.
4. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 334:1996;873-877.
5. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 336:1997;1-7.
6. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
7. Sundaram C.P., Thomas W., Pryor L.E., et al. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology. 49:1997;932-935.
8. Lea A.P., Bryson H.M., Balfour J.A. Intracavernous alprostadil A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction . Drugs Aging. 8:1996;56-74.
9. Physicians' Desk Reference, 51st ed. Montvale, NJ, Medical Economics, 1997, pp 864-865 (Regitine [phentolamine mesylate]), 1523 (papaverine hydrochloride).
10. Roy A.C., Adaikan P.G., Sen D.K., et al. Prostaglandin 15-hydroxydehydrogenase activity in human penile corpora cavernosa and its significance in prostaglandin-mediated penile erection. Br J Urol. 64:1989;180-184.
11. 1 with other intracavernous injections. Eur Urol. 26:1994;319-321.
12. Hedlund H., Hedlund P. Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models. Scand J Urol Nephrol. 179:1996;129-138.
13. Lipschultz L.I. Injection therapy for erectile dysfunction. N Engl J Med. 334:1996;913-914.
14. Becker A.J., Stief C.G., Machtens S., et al. Oral phentolamine as treatment for erectile dysfunction. J Urol. 159:1998;1214-1216.
15. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women Treatment of Mild Hypertension Study (TOMHS) . Hypertension. 29:1997;8-14.
16. Mann K., Klingler T., Noe S., et al. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav. 25:1996;1-16.
17. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF) a multidimensional scale for assessment of erectile dysfunction . Urology. 49:1997;822-830.
18. Kiely M.E., Thavundayil J.X., Lal S. Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence a case report . J Psychiatry Neurosci. 20:1995;233-235.
19. Flynn R.J., Williams G. Long-term follow-up of patients with erectile dysfunction commenced on self-injection with intracavernosal papaverine with or without phentolamine. Br J Urol. 78:1996;628-631.
20. Padma-Nathan H. The efficacy and synergy of polypharmacotherapy in primary and salvage therapy of vasculogenic erectile dysfunction. Int J Impotence Res. 2:1990;257-258.
21. Reid K., Surridge D.H., Morales A., et al. Double-blind trial of yohimbine in the treatment of psychogenic impotence. Lancet. 2:1987;421-423.
22. Gwinup G. Oral phentolamine in nonspecific erectile insufficiency. Ann Intern Med. 109:1988;162-163.
23. Zorgniotti A.W. Experience with buccal phentolamine mesylate for impotence. Int J Impotence Res. 6:1994;37-41.
24. 1-adrenoreceptors and uroselectivity. Prostate. 30:1997;202-215.